Announced
Completed
Financials
Sources
Tags
Majority
Single Bidder
Private
Biotechnology
treatment development
United States
biotechnology company
Friendly
Acquisition
Completed
Private Equity
Venture Capital
Cross Border
Synopsis
SoftBank Vision Fund 2 led a $165m funding round for Karius, a life sciences company focused on generating genomic insights for infectious diseases with a non-invasive blood test, with additional participation from General Catalyst, HBM Healthcare Investments, and existing investors Khosla Ventures and LightSpeed Venture Partners. "This transformative round will allow Karius to help more patients faster, fuel the next wave of clinical studies, and accelerate technology innovation. We are humbled to be part of the team that delivered the first clinical applications of microbial cell-free DNA and are excited about what's ahead for Karius," Mickey Kertesz, Karius CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.